Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pediatrics

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2016-2511PMID 27940717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

  2017cited by this paper
• Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.

  2017cited by this paper
• Early inhaled budesonide for the prevention of bronchopulmonary dysplasia

  2016cited by this paper
• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

  2015cited by this paper
• Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.

  2015cited by this paper
• Use of inhaled corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol

  2015cited by this paper
• An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia.

  2014cited by this paper
• Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

  2014cited by this paper
• Avoiding Endotracheal Ventilation to Prevent Bronchopulmonary Dysplasia: A Meta-analysis

  2013cited by this paper
• Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled Trial

  2013cited by this paper
• Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure

  2012cited by this paper
• Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

  2012cited by this paper
• Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

  2012cited by this paper
• Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

  2012cited by this paper
• A comprehensive approach to the prevention of bronchopulmonary dysplasia

  2011cited by this paper
• GRADE guidelines: 3. Rating the quality of evidence.

  2011cited by this paper
• Elaboration and Explanation ⋆

  2011cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Chorioamnionitis, Postnatal Factors and Proinflammatory Response in the Pathogenetic Sequence of Bronchopulmonary Dysplasia

  2009cited by this paper
• Assessing Risk of Bias in Included Studies

  2008cited by this paper
• Chapter 8: Assessing risk of bias in included studies

  2008cited by this paper
• Fluticasone Inhalation in Moderate Cases of Bronchopulmonary Dysplasia

  2005cited by this paper
• Methylxanthine Therapy for Apnea of Prematurity: Evaluation of Treatment Benefits and Risks at Age 5 Years in the International Caffeine for Apnea of Prematurity (CAP) Trial

  2005cited by this paper
• CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia

  2004cited by this paper
• Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.

  2003cited by this paper
• Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

  2003cited by this paper
• Neonatologists are using much less dexamethasone

  2003cited by this paper
• Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease.

  2002cited by this paper
• Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease

  2000cited by this paper
• Meter-dosed, inhaled beclomethasone initiated at birth to prevent bronchopulmonary dysplasia

  2000cited by this paper
• Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

  2000cited by this paper
• Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome

  1999cited by this paper
• Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.

  1999cited by this paper
• Early Treatment With Inhaled Steroids Does Not Improve Outcome in Extremely Premature Infants With Respiratory Distress † 1763

  1998cited by this paper
• Inhaled Budesonide in Ventilator- Dependent Preterm Infants: A Randomized, Double-Blind Pilot Study

  1998cited by this paper
• Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia

  1998cited by this paper
• Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study

  1998cited by this paper
• Effectiveness of budesonide aerosol in ventilator‐dependent preterm babies: A preliminary report

  1996cited by this paper
• Trial of Beclomethasone Dipropionate by Metered-Dose Inhaler in Ventilator-Dependent Neonates Less Than 1500 Grams

  1996cited by this paper
• Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants.

  1993cited by this paper

• Research progress on pathophysiologic mechanisms, clinical treatment and predictive biomarkers in bronchopulmonary dysplasia: from the perspective of oxidative stress

  2025cites this paper
• Uso terapêutico de corticosteroides inalados em prematuros com broncodisplasia pulmonar: Uma revisão de literatura dos últimos 25 anos

  2025cites this paper
• Point prevalence, characteristics and treatment variations for preterm infants with bronchopulmonary dysplasia in China: a ‘snapshot’ study

  2024cites this paper
• Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit

  2024cites this paper
• Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis.

  2024cites this paper
• Strategies for the prevention of bronchopulmonary dysplasia

  2024cites this paper
• Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia.

  2023cites this paper
• Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies

  2021cites this paper
• Pharmacoepidemiology of Drug Exposure in Intubated and Non-Intubated Preterm Infants With Severe Bronchopulmonary Dysplasia

  2021cites this paper
• Budesonide nebulization in preterm neonates with evolving brochopulmonary dysplasia after 14 days of life: a case series

  2021cites this paper
• Intra‐tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants

  2021cites this paper
• Current evidence for prenatal and postnatal corticosteroids in preterm infants

  2021cites this paper
• Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.

  2021cites this paper
• Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life

  2021cites this paper
• Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants

  2021cites this paper
• Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines

  2021cites this paper
• Budesonide mixed with surfactant did not affect neurodevelopmental outcomes at 6 or 18 months corrected age in observational cohorts

  2021cites this paper
• Extended Abstracts: IXth Recent Advances in Neonatal Medicine. An International Symposium Honoring Prof. B. Johnston Jr., October 1–3, 2021

  2021cites this paper
• Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia

  2021cites this paper
• Inhaled Budesonide in Neonatal Respiratory Distress Syndrome of Near-Term Neonates: A Randomized, Placebo-Controlled Trial.

  2021cites this paper
• Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta‐analysis

  2021cites this paper
• Early inhaled budesonide in extremely preterm infants decreases long‐term respiratory morbidity

  2020cites this paper
• Glucocorticoid Treatment for Bronchopulmonary Dysplasia

  2020cites this paper
• Bronchopulmonary dysplasia

  2020cites this paper
• Extended Abstracts: IXth Recent Advances in Neonatal Medicine. An International Symposium Honoring Prof. Richard B. Johnston Jr., MD, Denver, CO. Würzburg, October 1–3, 2021

  2020cites this paper
• Survival and Cause of Death among Extremely Preterm Infants Near the Limit of Viability

  2020cites this paper
• Efficiency of budesonide delivery via a mesh nebulizer in an in‐vitro neonatal ventilator model

  2020cites this paper
• Pharmacological Therapies for the Prevention of Bronchopulmonary Dysplasia

  2020cites this paper
• Impact of inhaled corticosteroids on the neurodevelopmental outcomes in chronically ventilated extremely low birth weight preterm infants.

  2020cites this paper
• Pediatric Pulmonology

  2020cites this paper
• Utilization trends of respiratory medication in premature infants discharged on home oxygen therapy

  2020cites this paper
• Pediatric Pulmonology

  2020cites this paper
• Bronchopulmonary dysplasia: how can we improve its outcomes?

  2019cites this paper
• Specialist neonatal respiratory care for babies born preterm

  2019cites this paper
• Metered‐dose inhaler therapy with spacers: Are newborns capable of using this system correctly?

  2019cites this paper
• Long‐term effects of the intratracheal administration of corticosteroids for the prevention of bronchopulmonary dysplasia: A meta‐analysis

  2019cites this paper
• Effect of airway administration of budesonide for bronchopulmonary dysplasia in premature infants: A Systematic Review and Meta-Analysis

  2019cites this paper
• From youth to adult : studies on chronic airway obstruction with special reference to events in the neonatal period

  2019cites this paper
• Surfactant and budesonide for respiratory distress syndrome: an observational study

  2019cites this paper
• Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal.

  2019cites this paper
• Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.

  2019cites this paper
• Prevention of Bronchopulmonary Dysplasia: A Summary of Evidence-Based Strategies.

  2019cites this paper
• Pediatric Pulmonology

  2019cites this paper
• Turkish Neonatal Society guideline on prevention and management of bronchopulmonary dysplasia

  2018cites this paper
• Respiratory Phenotypes for Preterm Infants, Children, and Adults: Bronchopulmonary Dysplasia and More

  2018cites this paper
• Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies

  2018cites this paper
• Long‐Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia

  2018cites this paper
• Are inhaled steroids safe and effective for prevention or treatment of bronchopulmonary dysplasia?

  2018cites this paper
• [Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants].

  2018cites this paper
• Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence

  2018cites this paper
• Effects of budesonide and surfactant in preterm fetal sheep.

  2018cites this paper
• Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study

  2018cites this paper
• Human milk as a protective factor for bronchopulmonary dysplasia: a systematic review and meta-analysis

  2018cites this paper
• Does inhaled budesonide for bronchopulmonary dysplasia affect the neurodevelopmental outcomes?

  2018cites this paper
• Surfactant, steroids and non-invasive ventilation in the prevention of BPD.

  2018cites this paper
• Inhaled corticosteroids and bronchopulmonary dysplasia

  2018cites this paper
• Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

  2018cites this paper
• Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates

  2018cites this paper
• Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cells

  2017cites this paper
• The use of inhaled corticosteroids in chronically ventilated preterm infants.

  2017cites this paper
• Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.

  2017cites this paper
• Inhaled Glucocorticoids and Pneumonia in Preterm Infants: Post Hoc Results from the NEuroSIS Trial

  2017cites this paper
• Using Quality Improvement Tools to Reduce Chronic Lung Disease.

  2017cites this paper
• What are the barriers to treatment in the developed world

  2017cites this paper
• Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.

  2017cites this paper
• State of the Art Review: Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants

  2017cites this paper
• Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.

  2017cites this paper
• The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment

  2017cites this paper
• Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis

  2017cites this paper
• [Readmission of children with bronchopulmonary dysplasia in the first 2 years of life: a clinical analysis of 121 cases].

  2017cites this paper
• Update on Postnatal Steroids

  2017cites this paper
• GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

  2016cites this paper